[quick news] on April 30, 2019, 10000 women blossomed -- the 15th "China Young Female Scientist Award"

On April 29, the 15th China Young Female Scientist Award Ceremony was held in Beijing, which was jointly held by all China Women's Federation, China Association for science and technology, China National Committee for UNESCO and L'Oreal China This award was awarded to a woman who has performed well in the fields of medicine, biology, earth science, aerospace science, etc They are: Ma Yuting, director of immune function testing and analysis platform, Suzhou Institute of systematic medicine, Chinese Academy of Medical Sciences, researcher, Niu Shuli, deputy director of laboratory, Institute of Geosciences and resources, Chinese Academy of Sciences, researcher, Liu Xiaohua, Professor, School of chemistry, Sichuan University, Liu Ying, researcher, Institute of molecular medicine, Peking University, deputy of discipline construction office, Northwest University of Technology Yang Hui, director and Professor, Zhang Xiaodan, director and researcher of Institute of optoelectronic thin film devices and technology, School of electronic information and optical engineering, Nankai University, Chen Lili, director of stomatology department, director of stomatology teaching and Research Office, Tongji Medical College, Huazhong University of science and technology, and Zhao, executive vice director and professor of Shanghai Hematology Research Institute, Ruijin Hospital, Shanghai Jiaotong University Wei Li, Yuan Yuan, researcher of Xi'an Institute of Optics and precision machinery, Chinese Academy of Sciences, Wei Shihui, researcher of rocket Army Research Institute, Chinese people's Liberation Army Http://news.sciencenet.cn/htmlnews/2019/4/425808.shtm the results of the preliminary examination of the National Natural Science Foundation Project Application in 2019 are announced and the National Natural Science Foundation Committee (hereinafter referred to as NSFC) has received 240711 projects of various types during the centralized acceptance of the project application in 2019 According to the regulations of NSFC, guidelines for NSFC projects in 2019, notice on application and conclusion of NSFC projects in 2019 and management measures for NSFC related types of projects, NSFC has preliminarily reviewed the project application After preliminary examination, NSFC has accepted 236890 project applications in total, and has not accepted 3821 project applications The NSFC will send the paper-based preliminary examination result notice to all supporting units, and notify the applicants who do not accept the project by e-mail The supporting unit can log in the network information system of NSFC to inquire about the acceptance of its own project application If the applicant has any questions about the decision of inadmissibility, he / she can consult with the relevant science department; if he / she has any objection to the decision of inadmissibility, he / she can apply to the relevant science department for reexamination before May 20, 2019 Http://nsfc.gov.cn/publish/portal0/tab434/info75881.htm? From = groupmessage & isappinstalled = 0 Chinese scientists have made new progress in breast cancer research Led by Professor Jiang zefei of the fifth medical center of the General Hospital of the Chinese people's Liberation Army, "phase III clinical study on the treatment of hormone receptor (HR) - positive postmenopausal breast cancer with xidabamide and exemestane" (ACE) Recently, it was published online in the international authoritative oncology journal Lancet Oncology The research results provide new treatment options for some breast cancer patients It is understood that the study conducted a randomized, double-blind, placebo-controlled phase III clinical trial in 22 research centers The study group received at least one endocrine treatment (rescue treatment or adjuvant treatment) for relapse or progress of HR positive and HER2 negative postmenopausal advanced breast cancer patients The results showed that the combination of selective histone deacetylase (HDAC) inhibitor and endocrinotherapy could significantly improve the survival benefit of HR positive and HER2 negative advanced breast cancer patients Https://www.sciencedirect.com/science/article/pii/s1470204519301640 Nankai University has developed the high temperature and cold resistant graphene material with large reversible deformation function, which is widely needed in various engineering applications However, at present, almost all the elastic and mechanical properties of high elastic materials will be affected by temperature, so it is impossible to maintain the excellent properties of materials in deep and low temperature environment such as outer space Recently, Professor Chen Yongsheng of School of chemistry of Nankai University and his team, together with Rice University of the United States, have developed a new three-dimensional graphene material, which is composed of disordered single-layer graphene sheets through covalent bond chemical crosslinking The material has the same mechanical properties as that at room temperature under extreme low temperature conditions as low as liquid helium temperature, including highly recoverable super elasticity and invariable Young's Modulus, near zero Poisson's ratio and excellent fatigue resistance The researchers pointed out that the remarkable mechanical stability of graphene and three-dimensional graphene materials makes them the best research object under the condition of deep and low temperature The new "space sponge" researched this time has a good application prospect in the field of aerospace equipment manufacturing Https://advances.sciencemag.org/content/5/4/eaav2589, the world's first professional intelligent identification instrument for gene sequencing of Chinese herbal medicine, released the important progress in gene identification research and industrialization of Chinese herbal medicine in China Hmbi-g30, the world's first intelligent identification instrument for gene sequencing of Chinese herbal medicine, has recently passed the acceptance in Beijing The instrument simplifies the complicated biological information process, can accurately, quickly and stably identify the samples of Chinese herbal medicine, and promotes the identification of Chinese herbal medicine into the era of standardization and intelligence According to Chen Shilin, director of the Institute of traditional Chinese medicine of the Chinese Academy of traditional Chinese medicine, the integrated high-throughput gene sequencing machine for Chinese herbal medicine DNA barcode released this time solves the problem of short reading length of high-throughput sequencing through fragment sequencing and comparison splicing; through dnbseqtm The technology can solve the problem of amplification sequence mixing, realize one-stop sequence processing and complete the whole process from original sequence to species identification, and use base proportion to replace the first generation sequence fluorescence intensity peak map to achieve a higher precision display of sequence details The research team conquered the upstream barriers of the industrial chain, completed the independent intellectual property rights and localization of hardware instruments, got rid of the dependence of Chinese herbal medicine gene identification on foreign instruments, and further consolidated China's international leading position in the field of Chinese herbal medicine gene identification   http://digitalpaper.stdaily.com/http_www.kjrb.com/kjrb/html/2019-04/30/content_420334.htm?div=-1